Development of a Scalable Process for an IL-17A Inhibitor LY3509754: Part III. Assembly of Drug Substance, Salt Formation, and Impurity Control

IF 3.1 3区 化学 Q2 CHEMISTRY, APPLIED
Qiang Yang*, Ryan J. Linder, Yu Lu, Thomas J. Beauchamp, Timothy A. Woods, David A. Coates, Brandon J. Reizman, Jonas Y. Buser, Michael E. Laurila, Nicholas A. Magnus, Yongjie Yu, Lili Han and Ping Huang, 
{"title":"Development of a Scalable Process for an IL-17A Inhibitor LY3509754: Part III. Assembly of Drug Substance, Salt Formation, and Impurity Control","authors":"Qiang Yang*,&nbsp;Ryan J. Linder,&nbsp;Yu Lu,&nbsp;Thomas J. Beauchamp,&nbsp;Timothy A. Woods,&nbsp;David A. Coates,&nbsp;Brandon J. Reizman,&nbsp;Jonas Y. Buser,&nbsp;Michael E. Laurila,&nbsp;Nicholas A. Magnus,&nbsp;Yongjie Yu,&nbsp;Lili Han and Ping Huang,&nbsp;","doi":"10.1021/acs.oprd.5c0000510.1021/acs.oprd.5c00005","DOIUrl":null,"url":null,"abstract":"<p >A 5-step cGMP sequence for the preparation of an IL-17A inhibitor <b>1</b> was optimized and scaled up to deliver a total of 66 kg of the final drug substance <b>1</b> to support clinical and product development studies. Salt formation and polymorph screening identified a suitable polymorph of the hemiedisylate salt that provided desirable physical properties. Key impurities in the final drug substance were identified, and control strategies were developed and executed to control them to acceptable levels in the production batches.</p>","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"29 4","pages":"1019–1035 1019–1035"},"PeriodicalIF":3.1000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Organic Process Research & Development","FirstCategoryId":"92","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.oprd.5c00005","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}
引用次数: 0

Abstract

A 5-step cGMP sequence for the preparation of an IL-17A inhibitor 1 was optimized and scaled up to deliver a total of 66 kg of the final drug substance 1 to support clinical and product development studies. Salt formation and polymorph screening identified a suitable polymorph of the hemiedisylate salt that provided desirable physical properties. Key impurities in the final drug substance were identified, and control strategies were developed and executed to control them to acceptable levels in the production batches.

Abstract Image

IL-17A抑制剂LY3509754可扩展工艺的开发:第三部分。原料药的组装、盐的形成和杂质控制
制备IL-17A抑制剂1的5步cGMP序列进行了优化和放大,以提供总共66公斤的最终药物1,以支持临床和产品开发研究。盐的形成和多晶型筛选确定了半二酸盐的合适多晶型,提供了理想的物理性能。确定最终原料药中的关键杂质,制定并执行控制策略,将其控制在生产批次中可接受的水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.90
自引率
14.70%
发文量
251
审稿时长
2 months
期刊介绍: The journal Organic Process Research & Development serves as a communication tool between industrial chemists and chemists working in universities and research institutes. As such, it reports original work from the broad field of industrial process chemistry but also presents academic results that are relevant, or potentially relevant, to industrial applications. Process chemistry is the science that enables the safe, environmentally benign and ultimately economical manufacturing of organic compounds that are required in larger amounts to help address the needs of society. Consequently, the Journal encompasses every aspect of organic chemistry, including all aspects of catalysis, synthetic methodology development and synthetic strategy exploration, but also includes aspects from analytical and solid-state chemistry and chemical engineering, such as work-up tools,process safety, or flow-chemistry. The goal of development and optimization of chemical reactions and processes is their transfer to a larger scale; original work describing such studies and the actual implementation on scale is highly relevant to the journal. However, studies on new developments from either industry, research institutes or academia that have not yet been demonstrated on scale, but where an industrial utility can be expected and where the study has addressed important prerequisites for a scale-up and has given confidence into the reliability and practicality of the chemistry, also serve the mission of OPR&D as a communication tool between the different contributors to the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信